🇺🇸 FDA
Patent

US 12156879

Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy

granted A61KA61K31/4439A61K31/506

Quick answer

US patent 12156879 (Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy) held by UNIVERSITY OF CONNECTICUT expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4439, A61K31/506, A61K31/541, A61K31/549